Fierce Healthcare
JANUARY 28, 2025
Chief among the questions raised by Monday's ambiguous memo are whether programs like Medicaid and SNAP as well as funding for clinical research, community health centers, suicide prevention and state infectious disease surveillance will see interruptions due to the pause.
IDStewardship
JANUARY 8, 2025
In this article, five key skills for pharmacy residents are identified and discussed. Authored by:Asma Alamri, Pharm.D. &Huda Almalki, Pharm.D. Post-Graduate Year-1Pharmacy Residents, Taif Health Cluster, Saudi Arabia Mentored by: Sameer Alzaidi, Pharm.D., BCPS, BCIDP, AAHIVP System-Wide Post-Graduate Year-1Pharmacy Residency Program Director, Taif Health Cluster, Saudi Arabia UNDER CONSTRUCTION Article Posted January 2024 According to the American College of Clinical Pharmacy (ACCP a reside
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JANUARY 8, 2025
Pharmacy professionals are used to overcoming obstacles in this competitive, dynamic field. But the coming year will bring challenges affecting patient care, the industry workforce and their business. Pharmacies must be ready to do more than weather the storm; they need deliberate strategy and sophisticated tools to thrive amidst these obstacles. This white paper will discuss the issues and solutions that should be at the top of every pharmacy professionals mind as they start the new year.
STAT
JANUARY 14, 2025
For the second time in less than a year, the U.S. Federal Trade Commission released a highly critical report of pharmacy benefit managers, which play a crucial but opaque role in the pharmaceutical supply chain. And the findings may provide further impetus for legislative action to curb practices that critics say contribute to the rising cost of prescription drugs.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
PharmaVoice
JANUARY 6, 2025
How regulators could hit PBMs from multiple sides in the coming year.
The Checkup by Singlecare
JANUARY 14, 2025
If youre living with diabeteswhether prediabetes , Type 2 diabetes , or Type 1 diabetes then youre probably taking steps to manage your blood glucose levels. Along with regular exercise, sufficient sleep, and taking care of your mental health, following a healthy, balanced meal plan is one of the most effective components of diabetes management. As you focus on maintaining healthy blood sugar levels, being mindful of your carbohydrate intake is likely at the forefront of your mind.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
The Guardian - Pharmaceutical Industry
JANUARY 4, 2025
Danish drug company gave money for Google ads to promote weight loss services and received data on web traffic and prescriptions The Danish drug company Novo Nordisk provided hundreds of thousands of pounds worth of sponsorship to pharmacies including Boots and Lloyds as it sought to boost sales of its slimming drugs in Britain, the Observer can reveal.
Drug Topics
JANUARY 30, 2025
A survey conducted by 3 Axis Advisors revealed potential impacts of the Inflation Reduction Acts Medicare Drug Price Negotiation Program.
STAT
JANUARY 18, 2025
A recent Nature Medicine research report is sounding an alarm. The risk of developing dementia by the age of 95 is 42%. The finding that the risk of dementia increases with age is well described. What’s new and startling about this result is the number. It’s double prior estimates. The investigator team, led by researchers at New York University and funded by the National Institutes of Health, reported even higher risk estimates for women, people who self-report Black racial identi
PharmaVoice
JANUARY 2, 2025
A handful of innovative startups are scrambling to gain a foothold as technology improves at a rapid clip.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
The Checkup by Singlecare
JANUARY 3, 2025
Contrave is a brand-name medication approved by the U.S. Food and Drug Administration (FDA) for chronic (long-term) weight management in certain adults. It should be taken with a reduced-calorie diet and increased physical activity. As a combination drug that contains an opioid antagonist and antidepressant, it affects the brain to make you feel fuller and lower your appetite.
European Pharmaceutical Review
JANUARY 7, 2025
The US Food and Drug Administration (FDA) has for the first time, issued draft guidance on using artificial intelligence (AI) intended to support a regulatory decision about a drug or biological product. The guidelines address the safety, effectiveness or quality of these medicines. FDA has previously published a discussion paper that was produced to inform its guidance on AI in pharmaceutical drug development.
Pharmacy Times
JANUARY 30, 2025
The drug is a selective NaV1.8 pain signal inhibitor and is the first new class of medication to treat acute pain in over 20 years.
Drug Topics
JANUARY 6, 2025
A study found that of 110 patients with long COVID, over half reported decreased QOL due to pain, discomfort, anxiety, or depression.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
JANUARY 6, 2025
After nearly a decade of machine learning innovation in the drug industry, the Food and Drug Administration Monday published its first draft guidance on the use of artificial intelligence in the development of drugs and biological products. The guidance comes as drug regulatory submissions citing AI have increased exponentially. In an interview with STAT in October, the FDA’s Tala Fakhouri, who co-leads the Center for Drug Evaluation and Research’s AI Council, said the agency has r
PharmaVoice
JANUARY 14, 2025
Merck looks ahead with an array of cardiometabolic, immunology, neuroscience and ophthalmology pipelines.
Fierce Healthcare
JANUARY 3, 2025
Mimicking prior federal and state investigations into drug manufacturers, health insurer Aetna is suing in Connecticut for rigging the generic drug market.
Pharmaceutical Technology
JANUARY 21, 2025
Innophore will launch the CavitOmiX AI tool to screen for new drugs, predict side effects, and repurpose existing molecules.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
JANUARY 21, 2025
Esketamine targets glutamate, the most abundant neurotransmitters in the brain.
Drug Topics
JANUARY 7, 2025
Researchers compared simultaneous and sequential administration of the mRNA COVID-19 and inactivated influenza vaccines.
STAT
JANUARY 18, 2025
After several years of investigation, the U.S. Department of Justice filed a civil lawsuit accusing Walgreens of illegally dispensing millions of prescriptions for opioid painkillers and failing to fulfill its role as a critical gatekeeper in the nation’s health care system. The lawsuit is only the latest to blame one of the largest pharmacy chains in the U.S. for contributing to a long-running opioid crisis that has led to the death of hundreds of thousands of Americans.
PharmaVoice
JANUARY 27, 2025
Coya Therapeutics is entering into a phase 2b study for its ALS, and the biotech’s CEO believes it’s on the cusp of a game changer.
Fierce Healthcare
JANUARY 9, 2025
Hippocratic AI is kicking off 2025 with a bang. The startup, which is building a large language model specifically for healthcare use cases, banked a $141 million series B financing round only nine months after its series A round.
PhRMA
JANUARY 24, 2025
It has been widely acknowledged that long patent examination delays cripple innovation, hinder economies, impede job creation and frustrate the launch of new products. Increased patent review times cost the global economy $10 billion annually, and are particularly harmful for small start-up firms. Every year of delay reduces the start-up’s employment growth by 21% and sales growth by 28% over the five years following the approval of the patent application.
Pharmacy Times
JANUARY 10, 2025
As of January 10, there are 5 major fires across a combined 36,560 acresPalisades, Eaton, Kenneth, Hurst, and Lidiaand the 2 largest fires are a combined 11% contained.
Drug Topics
JANUARY 17, 2025
Researchers wanted to better understand the accuracy of advertising practices behind websites selling compounded GLP-1 RAs.
STAT
JANUARY 16, 2025
SAN FRANCISCO — On the first day of the J.P Morgan Healthcare Conference, a small crowd of demonstrators gathered on a corner of Union Square just opposite of the conference’s main venue, the Westin St. Francis hotel. It was a varied crew — musicians, health care workers, teachers, and others. Steve Zeltzer, a labor journalist and organizer, spoke before the group and held a sign saying, “No more Deny, Delay, Depose,” alluding to words inscribed on the bu
PharmaVoice
JANUARY 9, 2025
Candel Therapeutics’ CEO had to prioritize a phase 3 program amid layoffs and cuts, and an end-of-year clinical success was the redemption he was looking for.
Fierce Healthcare
JANUARY 2, 2025
In this month's payer roundup, CVS faces antitrust questions from Congress as the company lays off more workers following a failed Medicaid bid in Kansas, Oscar Health CEO Mark Bertolini has a bold idea to remake health insurance and Johnson & Johnson is suing Express Scripts in a long-running lawsuit.
PhRMA
JANUARY 10, 2025
Ahead of next week’s J.P. Morgan Healthcare Conference, several PhRMA board members spoke with investors during a virtual conversation about what the new Congress and administration should focus on as they set their 2025 health care agenda.
Pharmacy Times
JANUARY 28, 2025
The new indication for semaglutide adds to the long list of conditions that the GLP-1 receptor agonist has been approved for, and provides a new option for high-risk patients with these chronic conditions.
Drug Topics
JANUARY 25, 2025
Among a population of patients with type 2 diabetes, researchers assessed the similarities and differences between SGLT2 inhibitors.
STAT
JANUARY 15, 2025
Over the last week, companies developing artificial intelligence products for health care have announced a series of impressive fundraises that set the tone for what could be a banner year for AI investment. Timed to the J.P. Morgan Healthcare conference, the announcements include $245 million for Innovaccer, a health care data company that’s increasingly focused on AI, $141 million for Hippocratic AI, a company that develops generative AI agents to help with clinical tasks, and $105 mill
Expert insights. Personalized for you.
142 
Let's personalize your content